Over the first two decades of experience with in vitro fertilization (IVF), embryos were routinely cultured for two to three days in the laboratory, and then transferred to the uterus. This is quite different than when embryos normally enter the uterus (day 5 or 6). After two or three days of growth inside the body embryos are found in the fallopian tubes and may not be ready to enter the uterus. Recently, laboratory culture conditions have been improved so that embryos can develop to the blastocyst stage in the laboratory, and therefore be replaced into the uterus at the more “natural” time, Day 5 or 6 after fertilization.
The additional benefit of waiting longer to transfer embryos is reducing the number of embryos needed to be transferred to result in a viable pregnancy. By culturing embryos to the blastocyst stage we have more opportunity to choose the healthiest ones for transfer. So, optimal pregnancies rates may be obtained by transferring fewer embryos and reducing multiple pregnancy rates.
Why RMA of New York: Blastocyst Transfer
For the past 20 years, RMA of New York has successfully facilitated the births of thousands of healthy babies for patients across the New York area. As the Division of Reproductive Endocrinology and Infertility of the Icahn School of Medicine at Mount Sinai, our team is dedicated to scientific discovery, medical excellence, and compassionate, patient-focused care. We are proud to be a member of the Department of Obstetrics, Gynecology, and Reproductive Science at the Mount Sinai Health System, which is recognized as a Center of Excellence by U.S. News & World Report.